Drilling begins at Stonepark Zinc Project

10^th September 2020

Arkle Resources PLC

("Arkle" or the "Company")

Drilling begins at Stonepark Zinc Project

Arkle Resources (AIM:ARK), the Irish Gold and Zinc resources discovery company, is pleased to announce that drilling has commenced on their Stonepark zinc project ("Stonepark" or the "Project"). Stonepark is a joint venture between Arkle (23.44%) and Group Eleven Resources Corp. ("Group 11") (76.56%). Group 11 is the operator of the Project. Below is an excerpt from the press announcement made by Group 11 today.

Highlights:

·    Drill program at Stonepark consists of two step-out holes, planned to total approximately 810 metres (360 metres and 450 metres, respectively)

·    Holes will test extensions of the Stonepark Mineral Resource Estimate ("MRE")

·    Stonepark MRE totals 5.1 million tonnes grading 8.7% zinc and 2.6% lead (11.3% combined) in the Inferred Category, located approximately one kilometre west of the Pallas Green zinc-lead deposit, with inferred resources of 45.4 million tonnes of 7% Zinc and 1% Lead.

The Stonepark project is located in the Limerick basin, in south-western Ireland (see Exhibit 1). Stonepark is adjacent to Group 11's 100% interest PG West project (which hosts the Carrickittle zinc prospect) and Glencore's Pallas Green project (which hosts the Pallas Green zinc-lead deposit).

John Teeling, Chairman and CEO, commented, "This is good news for shareholders. We are very well positioned in the emerging zinc province in the Limerick basin. These targeted holes are expected to grow the existing 5 million plus tonne resource."

Link to Exhibit 1. Location of the Stonepark Zinc Project (and adjacent PG West Project), south-west Ireland

http://www.rns-pdf.londonstockexchange.com/rns/6355Y_1-2020-9-10.pdf

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

ENDS

Enquiries: